Jushi Holdings (JUSHF) Income from Continuing Operations (2021 - 2026)
Jushi Holdings (JUSHF) reported Income from Continuing Operations of 19847000.0 for Q1 2026, down 16.64% year-over-year from 23809962.98 in Q1 2025, and down 27.58% quarter-over-quarter from 15556000.0 in Q4 2025.
Jushi Holdings (JUSHF) Income from Continuing Operations (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Income from Continuing Operations data on file, last reported at 19847000.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 19847000.0, down 16.64% year-over-year; the trailing twelve-month figure through Mar 2026 was 71423000.0 (down 50.56% YoY), and the FY2025 annual result was 68591000.0, down 40.62% from the prior year.
- Income from Continuing Operations slipped to 19847000.0 in Q1 2026 per JUSHF's latest filing, from 15556000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 12066000.0 in Q2 2022 and troughed at 139937000.0 in Q4 2022.
- A 5-year average of 23802411.76 and a median of 17015000.0 in 2025 frame the typical range for Income from Continuing Operations.
- On a YoY basis, Income from Continuing Operations climbed as much as 357.74% in 2022 and fell as far as 2353.05% in 2022.
- A 5-year view of Income from Continuing Operations shows it stood at 139937000.0 in 2022, then surged by 87.13% to 18004000.0 in 2023, then surged by 30.75% to 12468000.0 in 2024, then dropped by 24.77% to 15556000.0 in 2025, then slipped by 27.58% to 19847000.0 in 2026.
- Business Quant data shows JUSHF's Income from Continuing Operations at 19847000.0 in Q1 2026, 15556000.0 in Q4 2025, and 23689000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | Jushi Holdings | - | - | 29.88 Mn | -19.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.85 Mn |
| Dec 31, 2025 | -15.56 Mn |
| Sep 30, 2025 | -23.69 Mn |
| Jun 30, 2025 | -12.33 Mn |
| Mar 31, 2025 | -17.02 Mn |
| Dec 31, 2024 | -12.47 Mn |
| Sep 30, 2024 | -16.02 Mn |
| Jun 30, 2024 | -1.94 Mn |
| Mar 31, 2024 | -18.36 Mn |
| Dec 31, 2023 | -18.00 Mn |
| Sep 30, 2023 | -20.62 Mn |
| Jun 30, 2023 | -14.04 Mn |
| Mar 31, 2023 | -12.44 Mn |
| Dec 31, 2022 | -139.94 Mn |
| Sep 30, 2022 | -54.70 Mn |
| Jun 30, 2022 | 12.07 Mn |
| Mar 31, 2022 | -19.76 Mn |
| Dec 31, 2021 | 6.21 Mn |
| Sep 30, 2021 | 39.68 Mn |
| Jun 30, 2021 | 2.64 Mn |